Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response

被引：10
作者：
Kudo, M.
机构：
来源：
LIVER CANCER | 2016年 / 5卷 / 03期
关键词：
ALPHA-FETOPROTEIN LEVELS; INTERFERON THERAPY; ERADICATION; PROTEIN; HEPATOCARCINOGENESIS; INFECTION; PREDICT;
D O I：
10.1159/000443563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：155 / 161
页数：7
相关论文
共 25 条
[1]   α-Fetoprotein Levels After Interferon Therapy and Risk of Hepatocarcinogenesis in Chronic Hepatitis C [J].
Asahina, Yasuhiro ;
Tsuchiya, Kaoru ;
Nishimura, Takashi ;
Muraoka, Masaru ;
Suzuki, Yuichiro ;
Tamaki, Nobuharu ;
Yasui, Yutaka ;
Hosokawa, Takanori ;
Ueda, Ken ;
Nakanishi, Hiroyuki ;
Itakura, Jun ;
Takahashi, Yuka ;
Kurosaki, Masayuki ;
Enomoto, Nobuyuki ;
Nakagawa, Mina ;
Kakinuma, Sei ;
Watanabe, Mamoru ;
Izumi, Namiki .
HEPATOLOGY, 2013, 58 (04) :1253-1262
[2]   Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection [J].
Asahina, Yasuhiro ;
Tsuchiya, Kaoru ;
Tamaki, Nobuharu ;
Hirayama, Itsuko ;
Tanaka, Tomohiro ;
Sato, Mitsuaki ;
Yasui, Yutaka ;
Hosokawa, Takanori ;
Ueda, Ken ;
Kuzuya, Teiji ;
Nakanishi, Hiroyuki ;
Itakura, Jun ;
Takahashi, Yuka ;
Kurosaki, Masayuki ;
Enomoto, Nobuyuki ;
Izumi, Namiki .
HEPATOLOGY, 2010, 52 (02) :518-527
[3]   The Incidence and Risk Factors for the Development of Hepatocellular Carcinoma after Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C [J].
Dohmen, Kazufumi ;
Kawano, Akira ;
Takahashi, Kazuhiro ;
Shigematsu, Hirohisa ;
Tanaka, Hirofumi ;
Haruno, Masatora ;
Yanagita, Kimihoko ;
Ichiki, Yasunori ;
Mori, Tetsu ;
Hayashida, Kazuhiro ;
Shimoda, Shinji ;
Ishibashi, Hiromi ;
Nomura, Hideyuki .
HEPATO-GASTROENTEROLOGY, 2013, 60 (128) :2034-2038
[4]   Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients [J].
Hirakawa, Miharu ;
Ikeda, Kenji ;
Arase, Yasuji ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Hosaka, Tetsuya ;
Sezaki, Hitomi ;
Akuta, Norio ;
Kobayashi, Masahiro ;
Saitoh, Satoshi ;
Suzuki, Fumitaka ;
Suzuki, Yoshiyuki ;
Kumada, Hiromitsu .
INTERNAL MEDICINE, 2008, 47 (19) :1637-1643
[5]   Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon [J].
Ikeda, M ;
Fujiyama, S ;
Tanaka, M ;
Sata, M ;
Ide, T ;
Yatsuhashi, H ;
Watanabe, H .
JOURNAL OF GASTROENTEROLOGY, 2005, 40 (02) :148-156
[6]   Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy [J].
Iwasaki, Y ;
Takaguchi, K ;
Ikeda, H ;
Makino, Y ;
Araki, Y ;
Ando, M ;
Kobashi, H ;
Kobatake, T ;
Tanaka, R ;
Tomita, M ;
Senoh, T ;
Kawaguchi, M ;
Shimoe, T ;
Manabe, K ;
Kita, K ;
Shimamura, J ;
Sakaguchi, K ;
Shiratori, Y .
LIVER INTERNATIONAL, 2004, 24 (06) :603-610
[7]   Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C [J].
Kasahara, A ;
Hayashi, N ;
Mochizuki, K ;
Takayanagi, M ;
Yoshioka, K ;
Kakumu, S ;
Iijima, A ;
Urushihara, A ;
Kiyosawa, K ;
Okuda, M ;
Hino, K ;
Okita, K .
HEPATOLOGY, 1998, 27 (05) :1394-1402
[8]   Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients [J].
Kobayashi, S. ;
Takeda, T. ;
Enomoto, M. ;
Tamori, A. ;
Kawada, N. ;
Habu, D. ;
Sakaguchi, H. ;
Kuroda, T. ;
Kioka, K. ;
Kim, S. R. ;
Kanno, T. ;
Ueda, T. ;
Hirano, M. ;
Fujimoto, S. ;
Jomura, H. ;
Nishiguchi, S. ;
Seki, S. .
LIVER INTERNATIONAL, 2007, 27 (02) :186-191
[9]  
Kohayashi S, 2007, LIVER INT, V27, P186
[10]   Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe [J].
Kudo, M. .
LIVER CANCER, 2015, 4 (02) :85-95
123